Manufacturing’s Role in Advancing ADC Therapies
Antibody-drug conjugates have revolutionized oncology by merging targeted monoclonal antibodies with powerful cytotoxic agents to eradicate cancer cells precisely. As global sales continue to rise, driven by strategic collaborations and innovative technologies, the potential of ADCs in cancer treatment expands, paving the path for breakthrough therapies and strategic market advancements. The Evolution of Antibody Drug […]
3 minute read